Smaller panel, similar results: genomic profiling and molecularly informed therapy in pancreatic cancer
T.M. Reissig1,2,3,4, I. Tzianopoulos1,2,3, S.-T. Liffers1,2,4, V.K. Rosery1,2,3,4, M. Guyot3,5, S. Ting6, M. Wiesweg3,4, S. Kasper3,4, P. Meister7, T. Herold6, H.H. Schmidt8, B. Schumacher9, D. Albers9, P. Markus10, J. Treckmann7, M. Schuler3,4, H.-U. Schildhaus4,6, J.T. Siveke1,2,3,4
1Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Hospital Essen, Essen, Germany
2Division of Solid Tumor Translational Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Heidelberg, Germany
3Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany
4German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany
5Department of Gastroenterology, Oncology und Hematology, Diabetology and Rheumatology, Marien-Hospital Wesel, Wesel, Germany
6Institute of Pathology, West German Cancer Center, University Hospital Essen, Essen, Germany
7Department of General, Visceral and Transplantation Surgery, Hepatology, and Transplant Medicine, University Hospital Essen, Essen, Germany
8Department of Gastroenterology, Hepatology, and Transplant Medicine, University Hospital Essen, Essen, Germany
9Department of Gastroenterology, Visceral and Trauma Surgery, Elisabeth Hospital Essen, Essen, Germany
10Department of General, Visceral and Trauma Surgery, Elisabeth Hospital Essen, Essen, Germany